Stay updated on PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page.

Latest updates to the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check36 days agoNo Change Detected
- Check43 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check50 days agoChange DetectedThe website has been updated to Revision v2.14.2, while the previous version v2.14.1 has been removed due to end of life issues.SummaryDifference0.1%
- Check65 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check72 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check100 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
Stay in the know with updates to PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page.